Inclisiran Effectiveness in China: a Pragmatic Randomized Trial

Summary

The current study will be conducted to evaluate the real-world effectiveness of inclisiran relative to standard of care (SoC) in Chinese patients with coronary heart disease (CHD), not only with the low-density lipoprotein cholesterol (LDL-C) change in 1 year, but also the LDL-C Test on Target for 1 year. This study further aims to assess the adherence, treatment patterns and satisfaction, and safety of inclisiran among Chinese patients.

Timeline

Start

2025-06-17

Primary completion

2027-04-30

Completion

2027-04-30

Drugs

Indications